Velphoro Special Precautions

Peritonitis, gastric and hepatic disorders and gastrointestinal surgery: Patients with a recent history of peritonitis (within the last 3 months), significant gastric or hepatic disorders and patients with major gastrointestinal surgery have not been included in clinical studies with Sucroferric Oxyhydroxide (Velphoro). Sucroferric Oxyhydroxide (Velphoro) treatment should only be used in these patients following careful assessment of benefit/risk.
Discoloured stool: Sucroferric Oxyhydroxide (Velphoro) can cause discoloured (black) stool. Discoloured (black) stool may visually mask gastrointestinal bleeding (see as follows).
Information about sucrose and starches (carbohydrates): Sucroferric Oxyhydroxide (Velphoro) contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicinal product. May be harmful to the teeth.
Sucroferric Oxyhydroxide (Velphoro) contains starches. Patients with diabetes should take notice that one tablet of Sucroferric Oxyhydroxide (Velphoro) is equivalent to approximately 1.4 g of carbohydrates (equivalent to 0.116 bread units).
Effects On Ability to Drive and Use Machines: Sucroferric Oxyhydroxide (Velphoro) has no or negligible influence on the ability to drive and use machines.